Thomas A. MCCOURT - 17 Jan 2025 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role
Chief Executive Officer, Director
Signature
/s/ Brian Tessler, Attorney-in-Fact
Issuer symbol
IRWD
Transactions as of
17 Jan 2025
Transactions value $
$0
Form type
4
Filing time
22 Jan 2025, 16:35:33 UTC
Previous filing
17 Jun 2024
Next filing
12 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRWD Class A Common Stock Award $0 +147K +12.79% $0.00 1.3M 17 Jan 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares earned upon satisfaction of certain performance criteria associated with performance-based restricted stock units (PSUs) granted March 8, 2022. The earned PSUs were certified and vested on January 17, 2025.
F2 The reporting person acquired 2,014 shares of Class A Common Stock under the issuer's employee stock purchase plan on June 30, 2024.